Reuters Pharma 2025: Pre-Conference Talks Featuring Ana Cerdeira
Ana Cerdeira, Vice President, Global Head Commercial, Development Assets, Innovative Medicines Group, Grunenthal in a stimulating conversation with PharmaShots’ Managing Director Himanshu Sehgal.
Ana will be joining the upcoming Reuters Events Pharma 2025 as a panelist for the topic “Value unleashed: Elevate patient, HCP, and payer engagement with holistic storytelling tools and RWE”.
In this pre-conference talk, Ana emphasized generating insights to enhance the value proposition of products by integrating HCPs, patients, and payors.
Ana talks about the role of patient analytics, RWE, and PROs in enhancing patient engagement.
Image Source: Canva
About the Author:
Ana Cerdeira
Ana is a commercial leader with extensive experience in strategic advisory roles within the pharmaceutical and biotech sectors. Her career has been marked by significant contributions to high-impact projects and board-level strategies, particularly in pharma and innovative biotech.
Related Post: Reuters Pharma 2025: Pre-Conference Talks Featuring Kamya Elawadhi
Tags
Himanshu brings over 12 years of Pharma, Life Sciences, and Biotech expertise to Pharmashots. A self-proclaimed "Pharma Geek," his passion for the industry shines through. His career path blends hands-on lab research with high-level consulting at firms like PwC-Health Industries and Novartis. Himanshu holds a degree in Immunology from the University of Leeds, and boasts further credentials from IIM Lucknow and the London School of Economics. Connect with Himanshu to dive deeper into the dynamic world of pharmaceuticals and life sciences.
